Patents Assigned to Medtronic
-
Patent number: 8768029Abstract: A system and a method are disclosed that allow for generation of a model or reconstruction of a model of a subject based upon acquired image data. The image data can be acquired in a substantially mobile system that can be moved relative to a subject to allow for image acquisition from a plurality of orientations relative to the subject. The plurality of orientations can include a first and final orientation and a predetermined path along which an image data collector or detector can move to acquire an appropriate image data set to allow for the model of construction.Type: GrantFiled: October 20, 2010Date of Patent: July 1, 2014Assignee: Medtronic Navigation, Inc.Inventors: Patrick A. Helm, Shuanghe Shi
-
Patent number: 8768446Abstract: Methods of generating an extended cluster are disclosed. A first cluster including data representative of a first signal indicative of an abnormal physiological symptom is generated. A second signal is detected as representing a second abnormal physiological symptom and the second abnormal physiological symptom continues after the first abnormal physiological symptom ends. An extended cluster including the data from the first signal and the second signal is generated that extends from the time when the first abnormal physiological symptom occurs to the time when the second abnormal physiological symptom ends. The first and the extended cluster may include data of both the first and second signals the entire period of the clusters. If desired, the first signal or the second signal may be provided from a sensor implanted in a patient's brain tissue.Type: GrantFiled: April 26, 2006Date of Patent: July 1, 2014Assignee: Medtronic, Inc.Inventors: Touby A. Drew, Jonathan C. Werder, Jonathon E. Giftakis, Eric J. Panken
-
Patent number: 8767910Abstract: A system and a method for acquiring image data of a subject with an imaging system are provided. The system can include a gantry that completely annularly encompasses at least a portion of the subject, and a source positioned within the gantry. The source can be responsive to a signal to output at least one pulse. The system can include a multi-row detector positioned within the gantry. The multi-row detector can be in alignment with the source and sets multi-row detector data based on the detected at least one signal. The system can include a flat panel detector positioned within the gantry. The flat panel detector can in alignment with the source and sets flat panel detector data based on the detected at least one signal. The system can include an image acquisition control module that determines which of the multi-row detector and the flat panel detector to use.Type: GrantFiled: June 22, 2011Date of Patent: July 1, 2014Assignee: Medtronic Navigation, Inc.Inventors: Shuanghe Shi, Jason R. Chandonnet, Matthew G. Mooney
-
Patent number: 8764707Abstract: An insertion device, generally used with an infusion set, including a needle being adapted for puncturing at one end and including at the opposite end a hub. The hub includes a handle part and a guard part that are capable of securing the needle through the use of locks. Locking structures are used to secure the insertion device in a position where the needle is covered in a locked position, avoiding unintended contact with the needle.Type: GrantFiled: October 19, 2011Date of Patent: July 1, 2014Assignee: Medtronic Minimed, Inc.Inventors: Sheldon B. Moberg, Susie E. Maule, Mark D. Holt, Paul S. Cheney, II, Arin N. Holecek, Christopher G. Griffin, Julian D. Kavazov
-
Patent number: 8764745Abstract: A cryoprobe clamp for creating a lesion in a target tissue comprises a housing portion, a handle extending from the housing portion, a clamp assembly including a distal blade and a proximal blade structured for clamping a target tissue therebetween, a trigger mechanism positioned adjacent the handle and operably coupled to the clamp assembly, and an ablation tool extending between the housing portion and the clamp assembly. The distal blade includes receiving means structured to receive a distal portion of the ablation tool, and the proximal blade includes an outer frame surrounding an open window portion. Upon clamping the target tissue between the distal and proximal blades, a lesion formed by the distal end of the ablation tool is visible through the window portion of the proximal blade.Type: GrantFiled: January 26, 2009Date of Patent: July 1, 2014Assignee: Medtronic ATS Medical, Inc.Inventor: Andrzej M. Malewicz
-
Patent number: 8768459Abstract: One or more embodiments of the present disclosure relates to a method and/or system for classifying and/or treating heart rhythms. The present disclosure involves sensing electrical signals associated with depolarizations of a patient's heart. The sensed electrical signals are converted to digital values and storing the digital values. Normalizing solely a maximum and a minimum value of the stored digital values associated with a depolarization of the patient's heart without normalizing other stored digital values of the depolarization is another aspect of the present disclosure. The maximum and minimum values associated with the depolarization are compared to maximum and minimum values associated with a template derived from signals indicative of a heart depolarization of known type. A determination is made as to whether a match exists between the maximum and minimum values associated with the depolarization to the maximum and minimum values associated with a template.Type: GrantFiled: July 30, 2012Date of Patent: July 1, 2014Assignee: Medtronic, Inc.Inventors: Subham Ghosh, Jeffrey M. Gillberg
-
Patent number: 8765715Abstract: A method of providing hemostasis of bleeding tissue. A flexible bioresorbable foam is formed that consists essentially of carboxymethylcellulose. The flexible bioresorbable foam is crosslinked. Chain scission is performed on the crosslinked flexible bioresorbable foam to provide the flexible bioresorbable foam with a selected in-vivo residence time of between about 3 days and about 14 days. Hemostasis is caused by applying the flexible bioresorbable foam to bleeding tissue. The flexible bioresorbable foam is resorbed in-vivo. The selected in-vivo residence time is a time between the flexible bioresorbable foam being applied to the tissue and the flexible bioresorbable foam having been substantially completely absorbed into the tissue.Type: GrantFiled: November 20, 2012Date of Patent: July 1, 2014Assignee: Medtronic, Inc.Inventors: Dana A. Oliver, Matthew J. Halversen, Aimee Hodge
-
Patent number: 8764777Abstract: An endoventricular device includes a backbone and a plurality of segments having a plurality of anchors that are delivered to the treatment site in an inverted delivery configuration within a delivery catheter and when deployed moves from the inverted delivery configuration to a tissue penetrating implantation configuration.Type: GrantFiled: April 9, 2009Date of Patent: July 1, 2014Assignee: Medtronic Vascular, Inc.Inventor: Robert J. Melder
-
Patent number: 8768452Abstract: The disclosure is directed to a chronic implantable neurostimulator that supports trial and chronic modes of operation. The implantable neurostimulator can alternatively include one or more sensors that may or may not function differently in trial and chronic modes. In particular, the device is designed to be used as both a trial neurostimulator and a permanent, or chronic, neurostimulator. A trial neurostimulation period is generally desired to evaluate the efficacy of the therapy. A percutaneous or implantable trial neurostimulator is used for the trial neurostimulation period. In most cases, the trial period is successful, in which case the trial stimulator is explanted and replaced with a permanent, i.e., “chronic,” implantable stimulator. In accordance with the disclosure, an implantable neurostimulator supports both trial neurostimulation and chronic neurostimulation in the event trial stimulation is successful.Type: GrantFiled: April 28, 2005Date of Patent: July 1, 2014Assignee: Medtronic, Inc.Inventor: Martin T. Gerber
-
Patent number: 8768434Abstract: An volume of a patient can be mapped with a system operable to identify a plurality of locations and save a plurality of locations of a mapping instrument. The mapping instrument can include one or more electrodes that can sense a voltage that can be correlated to a three dimensional location of the electrode at the time of the sensing or measurement. Therefore, a map of a volume can be determined based upon the sensing of the plurality of points without the use of other imaging devices. An implantable medical device can then be navigated relative to the mapping data.Type: GrantFiled: April 14, 2009Date of Patent: July 1, 2014Assignee: Medtronic, Inc.Inventors: H. Toby Markowitz, Mustafa Karamanoglu, Pooja Mehta, Ioana Fleming, David A. Scanlon, Michael Kryger, Sean Campbell-Massa, Chad Giese, Steven L. Waldhauser, Shangqian Peter Zhang, Jeff Jannicke, Phillip Falkner, Don Hefner, Eduardo N. Warman, James Steeves, Rogier Receveur, Koen Michels, Olaf Eick, Vincent Larik
-
Publication number: 20140180278Abstract: A method of treating tissue is provided, including positioning a portion of a catheter in proximity to cardiac tissue; measuring an impedance value with the catheter; determining a respiratory rate based at least in part on the measured impedance value; and thermally treating the cardiac tissue with the catheter.Type: ApplicationFiled: February 27, 2014Publication date: June 26, 2014Applicant: Medtronic CryoCath LPInventors: Marwan ABBOUD, Johnny Al ASMAR, Chadi HARMOUCHE
-
Publication number: 20140180222Abstract: A system of catheter devices and methods for forming channels or passageways between a luminal anatomical structure (e.g., a blood vessel) and a target location (e.g., another blood vessel, an organ, a mass of tissue, etc.) for the purpose of rerouting blood flow or for delivering a substance or instrument, etc. to the target location.Type: ApplicationFiled: August 15, 2013Publication date: June 26, 2014Applicant: Medtronic Vascular, Inc.Inventors: J. Christopher Flaherty, Jason B. Whitt, Patrick E. Macaulay, David R. Tholfsen, John T. Garibotto, Philip C. Evard, Joshua Makower
-
Publication number: 20140180328Abstract: A sinus dilation instrument useful with a navigation system and including a handle, a rigid probe, a balloon, and an identifier device. The probe extends from the handle, forms a curved segment, and carries the balloon. The identifier device is programmed to generate a signal indicative of an instrument identification assigned to the instrument, and is a frontal, maxillary or sphenoid sinus instrument. The signal is formatted to be recognized by an IGS. Once connected, the IGS recognizes the instrument and can retrieve information indicative of a spatial location of the balloon, for example via an instrument tracking device. A surgeon can “plug and play” the sinus dilation instrument with the IGS to perform a procedure.Type: ApplicationFiled: December 21, 2012Publication date: June 26, 2014Applicant: Medtronic Xomed, Inc.Inventors: Robert K. Vaccaro, Charles Franklin Scott Carpenter, David J. Little, II, Ali Mowlai-Ashtiani, Matthew J. Nadeau, Dana A. Oliver
-
Publication number: 20140180401Abstract: Described is a prosthetic valve, comprising: an expandable stent including an inner lumen and having a first and a second end; and a spring attached to the first end of the expandable stent; wherein the expandable stent and the spring can expand radially to a desired diametric configuration in order to anchor the prosthetic valve at an implantation position in a body lumen. Related systems and methods.Type: ApplicationFiled: January 15, 2014Publication date: June 26, 2014Applicant: Medtronic, Inc.Inventors: Jason QUILL, Cynthia T. Clague, Paul T. Rothstein
-
Controlling effects caused by exposure of an implantable medical device to a disruptive energy field
Patent number: 8761886Abstract: Techniques are described for controlling effects caused when an implantable medical device (IMD) is subject to a disruptive energy field. The IMD may include an implantable lead that includes one or more electrodes. The IMD may further include a first component having a parasitic inductance. The IMD may further include a second component having a reactance. In some examples, the reactance of the second component may be selected based on the parasitic inductance of the first component such that an amount of energy reflected along the lead in response to energy produced by an electromagnetic energy source is below a selected threshold. In additional examples, the parasitic inductance of the first component and the reactance of the second component are configured such that an amount of energy reflected along the lead in response to a frequency of electromagnetic energy is below a selected threshold.Type: GrantFiled: June 30, 2010Date of Patent: June 24, 2014Assignee: Medtronic, Inc.Inventors: Christopher C. Stancer, Piotr J. Przybyszewski, Sandy K. Wixon, Joel Peltier, Sung-Min Park, David E. Manahan, Jonathan Edmonson, Ben W. Herberg -
Patent number: 8761890Abstract: In one example, the disclosure relates to a method comprising receiving at least one electrical stimulation parameter value defining electrical stimulation for delivery via one or more electrodes to a tissue site, and determining, via one or more processors, a volume of sub-activation threshold impact for tissue from the delivery of the electrical stimulation to the tissue site.Type: GrantFiled: January 24, 2013Date of Patent: June 24, 2014Assignee: Medtronic, Inc.Inventors: Rahul Gupta, Steven M. Goetz, Maciej T. Lazarewicz, Gabriela C. Molnar, Dwight E. Nelson, Jianping Wu
-
Patent number: 8761888Abstract: The disclosure describes a sensing device that is implantable to sense bladder conditions, as well as a neurostimulation system and method that make use of such a sensor for alleviation of urinary incontinence. The sensing device is implantable outside the bladder, but includes a lead that penetrates the bladder wall to deploy a sensor within the bladder. Using the sensor on the lead, the sensing device outside the bladder is able to detect a condition within the interior of the bladder. In this sense, the sensing device provides transmembrane sensing of internal bladder conditions. The condition may be indicative of bladder filling or bladder contraction, and may be used to control electrical stimulation applied to the patient to alleviate urinary incontinence.Type: GrantFiled: April 13, 2011Date of Patent: June 24, 2014Assignee: Medtronic, Inc.Inventor: Martin T. Gerber
-
Patent number: 8761881Abstract: Polarization signals, which represent voltages measured at a pacemaker electrode, are not constant and may drift. Polarization signal drift, which often precedes undesirable pace polarization artifacts, is more significant when the pacemaker is inhibited from providing an electrical stimulation to the patient's heart. The present invention provides an implantable system and methods for stabilization of a polarization signal. Electrical pulses may be applied to stabilize a polarization signal. In one implementation of the invention, polarization signal stabilization may be used as part of process to terminate tachycardia.Type: GrantFiled: July 24, 2006Date of Patent: June 24, 2014Assignee: Medtronic, Inc.Inventors: Bernardus F. M. Vonk, Gustaaf A. P. Stoop, Volkert Zeijlemaker
-
Patent number: 8758325Abstract: Thrombectomy catheters are presented that have curved tip portions. A suction lumen extends from at or near the proximal end of the catheter to a suction port at or near the tip portion of the catheter. The curves of the thrombectomy catheter can be selected to place a suction port at or near a vessel wall for the more effective removal of thrombus resulting from directing the suction in the direction of the thrombus. In some embodiments, the tip portion of the catheter can be transitioned from a first configuration for delivery of the catheter into the vessel to a second more curved configuration with a desired design for application of suction. The catheter can be moved in a circumferential and/or lateral direction to cover selected portions of the inner vessel wall. In some embodiments, a partially occlusive structure can be used to reduce and/or redirect flow within the vessel to improve performance of the thrombectomy.Type: GrantFiled: April 21, 2006Date of Patent: June 24, 2014Assignee: Medtronic, Inc.Inventors: Mark W. I. Webster, Jason A. Galdonik, Matthew F. Ogle, Edward Anderson, Gregory A. Boldenow
-
Patent number: 8758379Abstract: A surgical cutting instrument including two coaxially arranged tubular members. The first tubular member has a cutting tip and is co-axially disposed within the second tubular member, which in turn has a cutting window to expose the cutting tip to tissue and bone through the cutting window. Movement of the tubular members with respect to each other debrides soft tissue and thin bone presented to the cutting window. The second (outer) tubular member has one or more features which contribute to reduced clogging of the cutting tip as a whole.Type: GrantFiled: March 13, 2013Date of Patent: June 24, 2014Assignee: Medtronic-Xomed, Inc.Inventor: Joshua David Rubin